CAR19/22 T cell cocktail therapy for B- 1, Na Wang 2, Gaoxiang Wang 2, Liang Huang 2, Chunrui Li
一、高血压:(五大类 利尿剂,β受体阻滞剂,CCB,ACEI,ARB)1.原发性高血压:一般单用或联合 噻嗪类利尿剂,β受体阻滞剂,CCB,ACEI,ARB 联合用药:(三种以上 +
仅用于向医疗卫生专业人士提供科学信息,不代表平台立场审批编码:PP-IX-CN-4047 获批日期:2024年5月24日参考文献[1]https://immunology.knowledgehub
Hauspurg, MD, MS1,2; Kripa Venkatakrishnan, MPH3; Latima Collins, MD2; et alMalamo Countouris, MD
Nelson Sanchez-Pinto, MD, MBI1; Tellen D. Bennett, MD, MS2; Peter E. DeWitt, PhD3; et alSeth
A. Stringer, MD1; Teeranan Pokaprakarn, PhD2; Juan C. Prieto, PhD3; et alBellington Vwalika, MD
a systematic review and network meta-analysisFranco De Crescenzo 1, Gian Loreto D'Alò 2, Edoardo
A Randomized Clinical TrialLiqiang Zheng, MD, PhD1,2,3; Li Gai, MD4,5; Yani Wu, BS3; et alChaonan
Schuermans, BSc1,2,3; Buu Truong, MD1,2; Maddalena Ardissino, MBBS4,5; et alRohan Bhukar, MS1,2;